EUVIMEDEUVIMED entdecken
Crossref

Binding affinity of synthetic cannabinoids to human serum albumin by high-performance affinity chromatography

Santos, Rita M. G., Sara M. M. Cravo, Fernando Remião, Carla Fernandes

Science Letters · 28.04.2024

DOI: 10.48797/sl.2024.206 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Letters, erschienen am 28.04.2024. Verfasst von Santos und 4 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The use of new psychoactive substances (NPS) has been growing since the 2000’s, being the synthetic cannabinoids one of the groups reported on a larger scale. This group of NPS primarily interacts with the endocannabinoid system, which is involved in many physiological functions. Numerous reports of severe morbidity and mortality, linked to their consumption, have been documented [1,2]. Studies of toxicodynamics and toxicokinetics of synthetic cannabinoids are pivotal to increase the knowledge of this class of NPS. To our knowledge, studies of the interaction of synthetic cannabinoids with human serum albumin (HSA), the most abundant plasma protein, are still very limited [3].

Objective

This work aims the evaluation of binding affinity of a series of synthetic cannabinoids by high-performance affinity chromatography (HPAC). HPAC is a widely used and efficient technique to study intermolecular interactions between HSA and drugs [4,5].

Methods

The interaction of synthetic cannabinoids with HSA was investigated by HPAC by zonal elution experiments for measuring the retention times of each cannabinoid on an HSA column. Mixtures of potassium phosphate buffer (67 mM, pH 7.0) and acetonitrile were used as mobile phases in reversed elution mode.

Results

The binding percentages (%b) values ranged from 94 to 99%. ADB-FUBINACA and AMB-FUBINACA (MMB-FUBINACA) showed the highest binding affinity both with a %b of 99%.

Conclusions

The synthetic cannabinoids bounded to HSA with high affinity, which can interfere with drugs pharmacokinetics by increasing their free fraction in blood, as result of their eventual displacement from albumin or even by saturation of this protein. Zonal displacement chromatography studies are being conducted, using competitors with known specific binding sites on HSA, such as warfarin and (S)-ibuprofen, to shed light on the sites where the selected cannabinoids bind to the protein.

Schlagwörter

synthetic cannabinoidshuman serum albuminprotein binding affinitynew psychoactive substancesendocannabinoid systemdrug-protein interactionsdrug displacementtoxicokineticstoxicodynamics

Zitieren

APA

Santos, G., R. M., Cravo, S. M. M., Remião, F., & Fernandes, C. (2024). Binding affinity of synthetic cannabinoids to human serum albumin by high-performance affinity chromatography. Science Letters. https://doi.org/10.48797/sl.2024.206

Vancouver

Santos, G. RM, Cravo SMM, Remião F, Fernandes C. Binding affinity of synthetic cannabinoids to human serum albumin by high-performance affinity chromatography. Science Letters. 2024. doi:10.48797/sl.2024.206

BibTeX
@article{Santos2024,
  author = {Santos and G., Rita M. and Cravo, Sara M. M. and Remião, Fernando and Fernandes, Carla},
  title = {Binding affinity of synthetic cannabinoids to human serum albumin by high-performance affinity chromatography},
  journal = {Science Letters},
  year = {2024},
  doi = {10.48797/sl.2024.206}
}
Kostenlos starten →